IDiyas

For the Inventor, By the Inventor

Seeheim, Germany

Gunter Holzemann

USPTO Granted Patents = 13

Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 129(Granted Patents)


Location History:

  • Seehim, DE (1989)
  • Felding-Habermann, DE (1998)
  • Seeheim-Jugenheim, DE (1999)
  • Seeheim, DE (1987 - 2001)

Company Filing History:

goldMedal12 out of 1,248 
 
Merck Patent Gesellschaft MIT Beschrankter Haftung
 patents
silverMedal1 out of 28 
 
Merck Kgaa
 patents

Years Active: 1987-2001

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6333308 - Cyclic peptide derivatives (2001-12-25),
2. 6028080 - Quinolin-2-(1H)-ones (2000-02-22),
3. 6001961 - Cyclic adhesion inhibitors (1999-12-14),
4. 5866540 - Cyclic adhesion inhibitors (1999-02-02),
5. 5849692 - Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as (1998-12-15),
6. 5705481 - Cyclopeptides (1998-01-06),
7. 5693612 - Cyclopeptides of the formula I (1997-12-02),
8. 5215966 - Peptide and renin inhibitors (1993-06-01),
9. 4829053 - Amino acid derivatives (1989-05-09),
10. 4812555 - Peptides possessing renin inhibitory activity (1989-03-14),
11. 4755592 - Statine-containing peptides useful in medicaments (1988-07-05),
12. 4721776 - Amino acid derivatives (1988-01-26),
13. 4709010 - Peptides useful for inhibition of renin (1987-11-24),

Title: The Innovative Journey of Inventor Gunter Holzemann

Introduction:

Gunter Holzemann, a prolific inventor hailing from Seeheim, DE, has left a significant mark in the field of patents with a total of 13 patents to his credit. His relentless pursuit of innovation has led to groundbreaking discoveries in the realm of cyclic peptide derivatives and Quinolin-2-(1H)-ones.

Latest Patents:

Among his latest patents are the revolutionary Cyclic Peptide Derivatives and the cutting-edge Quinolin-2-(1H)-ones, showcasing his ability to push the boundaries of traditional pharmaceutical chemistry.

Career Highlights:

Holzemann has lent his expertise to renowned companies in the industry, notably Merck Patent Gesellschaft mit beschränkter Haftung and Merck KGaA, where his innovative spirit seamlessly blended with the companies' ethos of pioneering advancements in the pharmaceutical sector. His contributions have played a pivotal role in shaping the trajectory of pharmaceutical research and development.

Collaborations:

Throughout his illustrious career, Gunter Holzemann has collaborated with esteemed professionals in the field, including the likes of Alfred Jonczyk and Peter Raddatz. These collaborations have been instrumental in fostering a culture of innovation, leading to the creation of groundbreaking solutions that cater to the evolving needs of the industry.

Conclusion:

Inventor Gunter Holzemann's journey is a testament to the power of relentless innovation and collaboration in driving progress in the field of pharmaceuticals. His remarkable contributions through patents and collaborations have left an indelible impact, shaping the future of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…